Serotiny invents multi-domain therapeutic proteins
Serotiny partners with leaders in the life sciences to make better therapies and tools by designing multi-domain proteins with novel functionality. They tailor protein designs for unique demands including treatment of cancers and genetic disorders.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 16, 2015 | Grant | $149.96K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |